METTL3 and renal fibrosis: To validate the results obtained from the mouse CAR model, we applied clinical biopsy specimens from patients with CAR to assess the presence of MMT cells (co‐expressing CD68 and α‐SMA) and the METTL3 expression across different extents of renal fibrosis.